About Us
About Guard Therapeutics Vision and strategy The Board Management
Research & Development
Acute kidney injury ROSgard Scientific concept Clinical development Patents Publications
Investor Relations
Financial calender Financial reports Event calender Share information Corporate governance Articles of association Certified Adviser Rights issue 2021
News & Media
Press releases Reports and presentations In media Subscribe
Contact
Swe
Search

Press releases

All years 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Regulatory press releases Other press releases

We are dedicated to developing tomorrow’s drugs against oxidative stress, helping millions of people to a better life by preventing and treating serious kidney diseases. ROSgard, our biological drug candidate, mimics the body’s own powerful defense system against oxidative stress. Designed with a natural “homing” to the kidneys, ROSgard prevents kidney damage by protecting, cleaning and repairing the exposed cells and tissues.

Mail Address

Guard Therapeutics AB
Box 5216
102 45 Stockholm, Sweden

Visiting Address

Guard Therapeutics
Nybrogatan 34, 2 tr
114 39 Stockholm, Sweden

Telephone

+46 (0)8 670 65 51

E-mail

info@guardtherapeutics.com

Privacy Policy